Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
5 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
A Review of the Resistance Mechanisms for β-Lactams, Macrolides and Fluoroquinolones among Streptococcus pneumoniae.
Medicina (Kaunas). 2023 Oct 31;59(11):1927. doi: 10.3390/medicina59111927.
Medicina (Kaunas). 2023.
PMID: 38003976
Free PMC article.
Review.
Application of CRISPR-Cas System to Mitigate Superbug Infections.
Rabaan AA, Al Fares MA, Almaghaslah M, Alpakistany T, Al Kaabi NA, Alshamrani SA, Alshehri AA, Almazni IA, Saif A, Hakami AR, Khamis F, Alfaresi M, Alsalem Z, Alsoliabi ZA, Al Amri KAS, Hassoueh AK, Mohapatra RK, Arteaga-Livias K, Alissa M.
Rabaan AA, et al. Among authors: almaghaslah m.
Microorganisms. 2023 Sep 26;11(10):2404. doi: 10.3390/microorganisms11102404.
Microorganisms. 2023.
PMID: 37894063
Free PMC article.
Review.
Item in Clipboard
A rickettsia infection from Saudi Arabia.
Elzein FE, Aloteibi M, Alanazi W, Alsaeed M, Almaghaslah M.
Elzein FE, et al. Among authors: almaghaslah m.
Int J Infect Dis. 2020 Jan;90:167-169. doi: 10.1016/j.ijid.2019.10.042. Epub 2019 Nov 2.
Int J Infect Dis. 2020.
PMID: 31689527
Free article.
Item in Clipboard
A Trial of Favipiravir and Hydroxychloroquine combination in Adults Hospitalized with moderate and severe Covid-19: A structured summary of a study protocol for a randomised controlled trial.
Bosaeed M, Mahmoud E, Hussein M, Alharbi A, Alsaedy A, Alothman A, Aljeraisy M, Alqahtani H, Nashabat M, Almutairi B, Almaghaslah M, Aldibasi O, AlJohani S, Bouchama A, Arabi Y, Alaskar A.
Bosaeed M, et al. Among authors: almaghaslah m.
Trials. 2020 Oct 31;21(1):904. doi: 10.1186/s13063-020-04825-x.
Trials. 2020.
PMID: 33129363
Free PMC article.
Item in Clipboard
Favipiravir and Hydroxychloroquine Combination Therapy in Patients with Moderate to Severe COVID-19 (FACCT Trial): An Open-Label, Multicenter, Randomized, Controlled Trial.
Bosaeed M, Mahmoud E, Alharbi A, Altayib H, Albayat H, Alharbi F, Ghalilah K, Al Arfaj A, AlJishi J, Alarfaj A, Alqahtani H, Almutairi BM, Almaghaslah M, Alyahya NM, Bawazir A, AlEisa S, Alsaedy A, Bouchama A, Alharbi M, AlShamrani M, Al Johani S, Aljeraisy M, Alzahrani M, Althaqafi AO, Almarhabi H, Alotaibi A, Alqahtani N, Arabi YM, Aldibasi OS, Alaskar A.
Bosaeed M, et al. Among authors: almaghaslah m.
Infect Dis Ther. 2021 Dec;10(4):2291-2307. doi: 10.1007/s40121-021-00496-6. Epub 2021 Jul 28.
Infect Dis Ther. 2021.
PMID: 34319552
Free PMC article.
Item in Clipboard
Cite
Cite